Marimed Inc. (OTC: MRMD), an SEC filer in Medicinal Chemicals & Botanical Products, closed at $0.09, -3.2%, on 2026-08-28, with a market cap of $36M as of 2026-08-27, a net margin of -9.1% and 3-year sales growth of 5.1%. Institutional ownership, earnings history and filed financials are on the tabs below.
| Last reported | 2026-08-12 | Cadence | ~91d |
| Last surprise (SUE) | — | Typical earnings move | ±5.6% · n=12 |
A model's estimate — for research. See the Disclaimer.
| Fiscal quarter | Reported | EPS (diluted) | EPS YoY | Revenue | Rev YoY | Move | |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-12 | $-0.01 | — | $42M | +6.1% | −7.7% | |
| 2026-03-31 | 2026-05-13 | $-0.01 | — | $39M | +3.6% | −2.6% | |
| 2025-12-31 | 2026-03-11 | — | — | $42M | +7.0% | −3.3% | |
| 2025-09-30 | 2025-11-05 | $-0.01 | — | $41M | −0.3% | −6.0% | |
| 2025-06-30 | 2025-08-06 | $0.00 | — | $40M | −3.0% | −8.3% | |
| 2025-03-31 | 2025-05-07 | $-0.01 | — | $38M | −0.3% | −5.8% | |
| 2024-12-31 | 2025-03-05 | — | — | $39M | −0.7% | +0.7% | |
| 2024-09-30 | 2024-11-06 | $0.00 | — | $41M | +4.3% | −13.0% | |
| 2024-06-30 | 2024-08-07 | $0.00 | — | $41M | +10.3% | −1.6% | |
| 2024-03-31 | 2024-05-08 | $0.00 | — | $38M | +9.9% | −7.4% | |
| 2023-12-31 | 2024-03-06 | — | — | $39M | +5.8% | −10.1% | |
| 2023-09-30 | 2023-11-08 | $-0.01 | −200.0% | $39M | +14.2% | −1.1% |
The 10-K reports the fiscal year, not its fourth quarter — † marks a Q4 EPS we derived as the year minus the three quarters before it.
Move = the price reaction vs SPY around the report — a size, not a beat or miss.
